Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "generic"

716 News Found

Lupin launches fenofibrate in the US
Drug Approval | November 08, 2021

Lupin launches fenofibrate in the US

The drug helps in managing cholesterol


Venus Remedies H1 net profit rises 315%
News | November 03, 2021

Venus Remedies H1 net profit rises 315%

Venus Remedies has reported consolidated financial results for the period ended September 30, 2021


Novartis AG wins case against four domestic pharma firms
News | November 03, 2021

Novartis AG wins case against four domestic pharma firms

The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech


Dr. Reddy's launches Ephedrine Sulfate injection in the US
Drug Approval | November 01, 2021

Dr. Reddy's launches Ephedrine Sulfate injection in the US

The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021


Dr Reddys Laboratories  posts Q2FY22 PAT at Rs 992 Cr
News | November 01, 2021

Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr

Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021


MSD and MPP sign licensing agreement to make molnupiravir affordable
Biotech | October 28, 2021

MSD and MPP sign licensing agreement to make molnupiravir affordable

In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.


PLI scheme has the potential to make India a pharma hub: Dr Mandaviya
Policy | October 27, 2021

PLI scheme has the potential to make India a pharma hub: Dr Mandaviya

FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year


Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22
News | October 25, 2021

Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22

The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively


Biocon Q2FY22 in line with estimates, better margins: ICICI Direct
News | October 25, 2021

Biocon Q2FY22 in line with estimates, better margins: ICICI Direct

Key takeaways of recent quarter & conference call highlights


MediBuddy records a steep increase in dermatology consultation amongst youngsters
Startup | October 22, 2021

MediBuddy records a steep increase in dermatology consultation amongst youngsters

The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues